All materials

Resveratrol and immune signalling: STAT3, NF-κB and the contradictions of SIRT1

STAT3, NF-κB and NAD⁺-dependent deacetylation; conflicting Th17/Treg findings, pharmacokinetics and positive and negative clinical trials.